Effect of Pharmacological treatment on cardiac biomarkers in patients with acute coronary syndrome of non–ST segment elevation with Type-2 diabetes

Journal Title: International Journal of Medical and Health Sciences - Year 2016, Vol 5, Issue 1

Abstract

Background: The acute coronary syndrome is a consequence of coronary artery disease. Creatine Kinase MB is a cardiac biochemical marker used in the diagnosis and risk stratification of patients. The diabetes is a pathology associated to acute coronary syndrome non–ST segment elevation that change the cardiac conditions, in this sense, our objective was to evaluate the modifications of cardiac biomarkers values in diabetic patients. Materials and methods: A retrospective study included 155 patients of both sexes, ages ranging from 31 to 92 years old, admitted to the coronary unit of the “Reina Fabiola” Clinic, Córdoba, Argentina was performed in the period 2014-2015. Body mass index, time consultation pain, plasmatic Creatine Kinase isoenzyme MB activity and Troponin I levels were measured. The patients were stratified into two groups: without cardiovascular risk pathologies (Control group), n = 7; and with only type II diabetes, n = 64 treated with therapeutic doses of metformin (n= 37), and glibenclamide plus glizipide (n= 27). Results: cTnI levels were lower in both pharmacological treatments at 12 hrs when the values in control reach the highest. Similarly, CK-MB activity was lower at 8 hrs in both treatments; however at 12 hrs these values were lower only with metformin but not in glibenclamide plus glizipide treatment. These results could be showing an interaction between diabetes and pharmacological treatment upon the biomarkers values. Conclusion: The use of hypoglycemic drugs and the glycometabolic state are conditions that could modify CK-MB and cTnI release/clearance balance at 8 and 12 hrs after admission to the coronary unit.

Authors and Affiliations

Agustín N. JOISON, Gustavo BAIARDI

Keywords

Related Articles

A Case of Guillan Barre Syndrome Presenting with Hyperreflexia

Areflexia and progressive flaccid weakness are considered essential for diagnosis of Guillain-Barré syndrome (GBS) .We hereby report a case of a 41 year old male presenting with acute onset flaccid quadriparesis. Diagno...

Clinical, Endoscopic and Histological Findings of Carcinoma of Stomach

Background: Carcinoma of the stomach is a major cause of cancer mortality worldwide. The etiology and risk factors for gastric cancer includes environmental and genetic factors. Methods: The patients who attended surgic...

FimH Typing to Investigate Sub Clone Variations in ST69, ST127 and ST131 of Uropathogenic E. coli (UPEC) Isolates

Introduction: Multilocus sequence typing (MLST) used to characterize Uropathogenic Escherichia coli (UPEC) is not discriminatory enough because strains with identical sequence types (ST) may possess different genotypes...

Prevalence of Goitre among School Children in Kottayam, Kerala

Background: Iodine deficiency is the world’s single most important cause of preventable brain damage and mental retardation in the world. Goitre is one of the important manifestations of iodine deficiency. Generally it...

Knowledge and Awareness About Breast Cancer Among Primary Care Attendees in Al-Khobar City, Eastern Saudi Arabia

Background: Breast cancer is a serious problem and its incidence in Kingdom of Saudi Arabia (KSA) is still rising. Knowledge and awareness of women about breast cancer is important for prevention and early detection of...

Download PDF file
  • EP ID EP39941
  • DOI -
  • Views 268
  • Downloads 0

How To Cite

Agustín N. JOISON, Gustavo BAIARDI (2016). Effect of Pharmacological treatment on cardiac biomarkers in patients with acute coronary syndrome of non–ST segment elevation with Type-2 diabetes. International Journal of Medical and Health Sciences, 5(1), -. https://europub.co.uk/articles/-A-39941